4:06 pm Intercept Pharma receives Breakthrough Therapy Designation from FDA
for Obeticholic Acid for Nonalcoholic Steatohepatitis with liver
fibrosisBriefing.com(Thu 4:06PM EST)
Intercept Receives Breakthrough Therapy Designation From FDA for Obeticholic
Acid for Nonalcoholic Steatohepatitis (NASH) With Liver
FibrosisGlobeNewswire(Thu 4:05PM EST)
开始疯狂杀熊挤空。
a**u 发帖数: 8107
3
可惜我帐户没申请extend hour，没机会入了
【在 f*******1 的大作中提到】 : 4:06 pm Intercept Pharma receives Breakthrough Therapy Designation from FDA : for Obeticholic Acid for Nonalcoholic Steatohepatitis with liver : fibrosisBriefing.com(Thu 4:06PM EST) : Intercept Receives Breakthrough Therapy Designation From FDA for Obeticholic : Acid for Nonalcoholic Steatohepatitis (NASH) With Liver : FibrosisGlobeNewswire(Thu 4:05PM EST) : 开始疯狂杀熊挤空。
